ArticleBlood advances2026
Treatment-free remission and immune profiling after frontline second-generation TKI therapy in CML.
Naoto Takahashi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleBlood advances2026
Naoto Takahashi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.